Table II.
Respiratory Viruses Detected, According to Age Group Between 2012 and 2013
| Virus | <1 m, no (%) | 1–<2 m, no (%) | 2–<3 m, no (%) | 3–<6 m, no (%) | 6–<9 m, no (%) | 9–<12 m, no (%) | 1–<6 y, no (%) | 6–<13 y, no (%) | Total | P‐value |
|---|---|---|---|---|---|---|---|---|---|---|
| ADV | 2 (0.7) | 2 (1.0) | 6 (3.0) | 28 (8.3) | 19 (9.2) | 10 (7.5) | 53 (7.9) | 7 (3.7) | 127 (5.7) | <0.001 |
| hBoV | 0 (0.0) | 1 (0.5) | 1 (0.5) | 6 (1.8) | 7 (3.4) | 3 (2.3) | 15 (2.2) | 1 (0.5) | 34 (1.5) | 0.023 |
| NL63/229E/OC43 | 13 (4.5) | 5 (2.4) | 11 (5.5) | 11 (3.3) | 7 (3.4) | 7 (5.3) | 16 (2.4) | 7 (3.7) | 77 (3.4) | 0.35 |
| hEV | 3 (1.0) | 4 (1.9) | 5 (2.5) | 4 (1.2) | 1 (0.5) | 1 (0.8) | 17 (2.5) | 1 (0.5) | 36 (1.6) | 0.234 |
| IFLA | 4 (1.4) | 3 (1.4) | 4 (2.0) | 11 (3.3) | 7 (3.4) | 6 (4.5) | 29 (4.3) | 9 (4.8) | 73 (3.3) | 0.147 |
| IFLB | 2 (0.7) | 3 (1.4) | 1 (0.5) | 4 (1.2) | 3 (1.4) | 2 (1.5) | 20 (3.0) | 10 (5.3) | 45 (2) | 0.005 |
| hMPV | 6 (2.1) | 2 (1.0) | 10 (5.0) | 17 (5.1) | 13 (6.3) | 10 (7.5) | 32 (4.8) | 4 (2.1) | 94 (4.2) | 0.012 |
| PIV1 | 0 (0.0) | 3 (1.4) | 3 (1.5) | 5 (1.5) | 3 (1.4) | 5 (3.8) | 16 (2.4) | 2 (1.1) | 37 (1.7) | 0.129 |
| PIV2 | 1 (0.3) | 0 (0.0) | 2 (1.0) | 5 (1.5) | 1 (0.5) | 2 (1.5) | 9 (1.3) | 7 (3.7) | 27 (1.2) | 0.028 |
| PIV3 | 8 (2.8) | 11 (5.3) | 11 (5.4) | 18 (5.4) | 9 (4.3) | 3 (2.3) | 37 (5.5) | 6 (3.2) | 103 (4.6) | 0.435 |
| PIV4 | 5 (1.7) | 0 (0.0) | 3 (1.5) | 1 (0.3) | 2 (1.0) | 2 (1.5) | 5 (0.7) | 2 (1.1) | 20 (0.9) | 0.416 |
| hRV | 50 (17.4) | 44 (21.2) | 61 (30.2) | 63 (18.8) | 44 (21.3) | 30 (22.6) | 116 (17.2) | 32 (17.0) | 440 (19.7) | 0.006 |
| RSV A | 55 (19.1) | 51 (24.5) | 46 (22.8) | 74 (22.0) | 36 (17.4) | 25 (18.8) | 83 (12.3) | 11 (5.9) | 381 (17) | <0.001 |
| RSV B | 29 (10.1) | 14 (6.7) | 9 (4.5) | 15 (4.5) | 13 (6.3) | 14 (10.5) | 35 (5.2) | 2 (1.1) | 131 (5.9) | <0.001 |
m, month; y, year.